This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Cano Health Dividendo

Dividendo criteri di controllo 0/6

Cano Health non ha registrato alcun pagamento di dividendi.

Informazioni chiave

n/a

Rendimento del dividendo

n/a

Rapporto di remunerazione

Rendimento medio del settore	1.7%
Prossima data di pagamento dei dividendi	n/a
Data di stacco del dividendo	n/a
Dividendo per azione	n/a
Utile per azione	-US$207.63
Rendimento futuro dei dividendi	0%

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Feb 06

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Aug 11

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

Jun 20

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Jun 09

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

May 12

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di CANO.Q siano rimasti stabili in passato.

Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di CANO.Q siano aumentati.

Rendimento dei dividendi rispetto al mercato

Cano Health Rendimento dei dividendi rispetto al mercato

Come si colloca il rendimento da dividendo di CANO.Q rispetto al mercato?
Segmento	Rendimento dei dividendi
Azienda (CANO.Q)	n/a
Fondo del 25% del mercato (US)	1.5%
Top 25% del mercato (US)	4.5%
Media del settore (Healthcare)	1.7%
Analista previsionale (CANO.Q) (fino a 3 anni)	0%

Dividendo notevole: Impossibile valutare il rendimento dei dividendi di CANO.Q rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Dividendo elevato: Impossibile valutare il rendimento dei dividendi di CANO.Q rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.

Distribuzione degli utili agli azionisti

Copertura degli utili: Dati insufficienti per calcolare il payout ratio di CANO.Q per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.

Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché CANO.Q non ha segnalato alcun pagamento.

This company listing is no longer active

Cano Health Dividendo

Dividendo criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sui dividendi

Recent updates

First Motion for Exclusivity Period Extension Approved For Cano Health, Inc.

Fourth Amended Disclosure Statement Approved for Cano Health, Inc.

Fourth Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Third Amended Reorganization Joint Plan and Disclosure Statement Filed by Cano Health, Inc.

Second Amended Reorganization Plan and Disclosure Statement Filed by Cano Health, Inc.

First Amended Joint Reorganization and Disclosure Statement Plan Filed by Cano Health, Inc.

Motion for De Minimis Asset Sale Approved for Cano Health, Inc.

Cano Health, Inc. announced delayed annual 10-K filing

Interim DIP Financing Approved for Cano Health, Inc.

Motion for Joint Administration Filed by Cano Health, Inc.

NYSE to Commence Delisting Proceedings Against Cano Health

Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy

Cano Health, Inc. Filed for Bankruptcy

Cano Health Announces Appointment of Two New Independent Directors

Cano Health, Inc. announced delayed 10-Q filing

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Cano Health, Inc. Reports Unaudited Consolidated Goodwill Impairment Loss for the Third Quarter Ended September 30, 2023

Third quarter 2023 earnings released: US$91.87 loss per share (vs US$23.34 loss in 3Q 2022)

High number of new and inexperienced directors

Cano Health Provides Nasdaq Compliance Update

Cano Health, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Cano Health, Inc. Announces the Resignation of Mark Novell as Chief Accounting Officer

Cano Health Receives NYSE Notification Letter; Plans to Regain Compliance with Listing Rules

Cano Health, Inc. Appoints Mark Kent as Chief Executive Officer

Cano Health, Inc. announced delayed 10-Q filing

Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations

Price target decreased by 7.4% to US$2.67

Cano Health, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Cano Health, Inc. Announces Board Changes

Chief Clinical Officer recently sold US$709k worth of stock

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Issues a Response to Cano Health’s Post-Market Announcement

Cano Health: CEO Departure Could Be Constructive, New Skipper More So

New minor risk - Insider selling

Cano Health, Inc. Announces Chief Executive Officer Changes

Chief Clinical Officer recently sold US$1.2m worth of stock

Cano Health, Inc. Announces Announces Chief Executive Officer Changes

Chief Clinical Officer notifies of intention to sell stock

Elliot Cooperstone Posts Materials to his Website

Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile

Cano Health, Inc. Appoints Frederick Green as Interim Chief Legal Officer

Cano Health, Inc., Annual General Meeting, Jun 15, 2023

Consensus estimates of losses per share improve by 29%

Elliot Cooperstone Sends a Letter to the Shareholders of Cano Health, Inc

Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report

Stabilità e crescita dei pagamenti

Rendimento dei dividendi rispetto al mercato

Distribuzione degli utili agli azionisti

Pagamenti in contanti agli azionisti

Scoprire le società che pagano dividendi forti